Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, COVID-19, Hypertension, Mesenteric neoplasm, SARS-CoV-2 test positive
Clinical narrative: ? COVID-19 DISEASE       9/9/23: Asymptomatic PCR positive on admission.  Not a candidate for Paxlovid as she is asymptomatic.  If she becomes symptomatic within the next 4 days (5 days from positive test), recommend starting Paxlovid then.   ? CANCER METASTATIC TO OMENTUM   ? PAPILLARY SEROUS CARCINOMA, ENDOMETRIUM       Added automatically from request for surgery 2169270   ? INTERMITTENT ASTHMA   ? HTN (HYPERTENSION)   ? BMI 36-36.9 ADULT     Resolved Hospital Problems No resolved problems to display.     Reason for Hospitalization/Hospital Course/Significant Findings: Admitted for observation after episode of vaginal bleeding and passage of tissue PV.  Minimal bleeding on admission, hemoglobin stable, VSS.  Incidental finding of asymptomatic COVID+ on PCR.  Not a candidate for Paxlovid due to lack of symptoms, as noted above.  Stable for DC to home.  Will CC chart to ONC team.   Primary Procedures: None   Secondary Procedures: None   Complications: none   Subjective: Denies pain currently.  No CP/SOB/Diz/Palps.  No cough/wheezing/sputum/hemoptysis. She has been NPO during admission and is hungry.  Passing flatus. She is ambulating and voiding normally.   Physical Exam at discharge: BP 165/75  | Pulse 90  | Temp 98.1 °F (36.7 °C)  | Resp 18  | Ht 5' 6"  | Wt 108.4 kg (238 lb 15.7 oz)  | SpO2 100%  | Breastfeeding No  | BMI 38.57 kg/m²  General Appearance:  Alert, well appearing and in no distress Chest:  clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry Heart:  regular rate and rhythm, no murmurs Abdomen:  Soft, non-tender, non-distended Extremities:  no tenderness in the calves or thighs and no significant edema   Condition on discharge:  Stable.   Discharge Disposition:  Discharged home   Medications/Activity/Follow-up/Patient Instructions: See patient discharge instructions.   Pending Study Results at Discharge: None   Issues to be Addressed in Follow-up: Chemotherapy treatment plan in light of COVID+ PCR test           Note Details  Author  (M.D.) File Time 9/9/2023  9:21 AM Author Type Physician Status Addendum Last Editor  (M.D.) Specialty Obstetrics & Gynecology Hospital Acct #  Admit Date 9/8/2023  ED to Hosp-Admission (Discharged) on 9/8/2023  ED to Hosp-Admission (Discharged) on 9/8/2023   Revision History   Detailed Report  Note shared with patient Additional Orders and Documentation   Results    Meds    Orders    Flowsheets   Encounter Info:  History, Allergies, Education, Care Plan, Detailed Report   Hospital Problem List   HTN (HYPERTENSION)  INTERMITTENT ASTHMA  ABNL VAGINAL BLEEDING  BMI 36-36.9 ADULT  PAPILLARY SEROUS CARCINOMA, ENDOMETRIUM  CANCER METASTATIC TO OMENTUM  COVID-19 DISEASE  ENDOMETRIAL CANCER Care Timeline  09/08   Admitted from ED (Observation) 2153 09/09   Discharged 1332  Discharge   Home or Self Care.   Discharge Instructions (AVS) (Printed 9/9/2023) Medication List at Discharge   albuterol sulfate 90 mcg/actuation 2 Puffs Inhalation EVERY 4 HOURS AS NEEDED, . 100 days supply for asthma is 1 canister  amlodipine besylate 5 mg Oral DAILY  docusate sodium 100 mg Take 1 to 2 capsules by mouth at bedtime as needed for constipation  ergocalciferol (vitamin D2) 50,000 Units Oral WEEKLY  ibuprofen 800 mg Take 1 tablet by mouth 1 hour prior to procedure, then 1 tablet every 6 hours with food as needed for pain after procedure  morphine sulfate 15 mg Oral EVERY 6 HOURS AS NEEDED  ondansetron HCl 4 mg Take 1 tablet by mouth every 8 to 12 hours as needed for nausea or vomiting  oxycodone HCl 5 mg Oral EVERY 6 HOURS AS NEEDED  tramadol HCl 50 mg Oral EVERY 6 HOURS AS NEEDED